HUMANIGEN, INC Contracts & Agreements
107 Contracts & Agreements
- Business Finance (53 contracts)
- Business Operations (11)
- Human Resources (29)
- Intellectual Property (1)
- Real Estate (2)
- Uncategorized (11)
- Description of Registrants Director Compensation Policy (Filed With SEC on March 30, 2023)
- Settlement Agreement dated as of December 16, 2022, by and between the Registrant and Catalent Pharma Solutions, LLC (Filed With SEC on March 30, 2023)
- Employment Agreement, dated as of April 21, 2021, by and between Humanigen, Inc. and Dr. Adrian Kilcoyne (Filed With SEC on April 12, 2022)
- Description of Registrants Director Compensation Policy (Filed With SEC on March 1, 2022)
- Form of Incentive Stock Option Award Agreement under 2020 Omnibus Incentive Plan (Filed With SEC on August 12, 2021)
- Form of Non-qualified Stock Option Award Agreement under 2020 Omnibus Incentive Plan (Filed With SEC on August 12, 2021)
- Loan and Security Agreement, dated March 10, 2021, by and between the Registrant and Hercules Capital, Inc (Filed With SEC on May 13, 2021)
- Underwriting Agreement, dated March 30, 2021, by and among the Company, Jefferies LLC, Credit Suisse Securities (USA) LLC and Cantor Fitzgerald & Co., as representatives of the... (Filed With SEC on April 2, 2021)
- Description of Securities (Filed With SEC on March 10, 2021)
- INDEMNITY AGREEMENT (Filed With SEC on March 10, 2021)
- Amended and Restated Employment Agreement, dated as of October 29, 2020, by and between the Registrant and Dr. Cameron Durrant (Filed With SEC on March 10, 2021)
- Employment Agreement dated as of August 1, 2020, by and between the Registrant and Timothy Morris (Filed With SEC on March 10, 2021)
- Employment Agreement, dated as of July 6, 2020, by and between the Registrant and David Tousley (Filed With SEC on March 10, 2021)
- Amended and Restated Employment Agreement, dated as of September 24, 2020, by and between the Registrant and Dr. Dale Chappell (Filed With SEC on March 10, 2021)
- License Agreement, dated as of November 3, 2020, by and among the Registrant, KPM Tech Co., Ltd and Telcon RF Pharmaceutical, Inc (Filed With SEC on March 10, 2021)
- Amended and Restated Cooperative Research and Development Agreement, dated as of January 21, 2021, by and among the Registrant, Joint Program Executive Office for Chemical,... (Filed With SEC on March 10, 2021)
- Consulting Agreement, dated as of March 6, 2021, by and between the Registrant and David Tousley (Filed With SEC on March 10, 2021)
- Master Services Agreement effective as of January 8, 2021 between Humanigen, Inc. and EVERSANA Life Science Services, LLC (Filed With SEC on January 14, 2021)
- Controlled Equity OfferingSM Sales Agreement, dated December 31, 2020, by and between the Company and Cantor Fitzgerald & Co (Filed With SEC on December 31, 2020)
- Underwriting Agreement, dated September 17, 2020, by and among the Company, J.P. Morgan Securities LLC and Jefferies LLC, as representatives of the several underwriters (Filed With SEC on September 21, 2020)
- Humanigen, Inc. 2020 Omnibus Incentive Compensation Plan, effective September 11, 2020 (Filed With SEC on September 11, 2020)
- Form of Incentive Stock Option Award Agreement (Filed With SEC on September 11, 2020)
- Form of Non-qualified Stock Option Award Agreement (Filed With SEC on September 11, 2020)
- Form of Humanigen, Inc. 2020 Omnibus Incentive Compensation Plan (Filed With SEC on August 3, 2020)
- Clinical Trial Agreement, dated as of July 24, 2020, by and between Humanigen, Inc. and The National Institute of Allergy and Infectious Diseases (NIAID), part of the National... (Filed With SEC on July 30, 2020)
- Securities Purchase Agreement, dated as of June 1, 2020, by and among Humanigen, Inc. and the investors party thereto (Filed With SEC on June 15, 2020)
- Form of March 2020 Convertible Redeemable Promissory Notes dated March 13, 2020 and March 19, 2020 (Filed With SEC on May 15, 2020)
- Form of Amendment Number 3, dated March 20, 2020, to the Secured Bridge Note, dated June 28, 2019 (Filed With SEC on March 23, 2020)
- Form of Amendment Number 2, dated March 20, 2020, to the Secured Bridge Note, dated November 12, 2019 (Filed With SEC on March 23, 2020)
- DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 (Filed With SEC on March 16, 2020)
- Form of Amendment Number 2, dated December 30, 2019, to the Secured Bridge Note, dated June 28, 2019 and as amended on October 8, 2019 (Filed With SEC on December 31, 2019)
- Purchase Agreement, dated as of November 8, 2019 by and between Humanigen, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on November 12, 2019)
- Registration Rights Agreement, dated as of November 8, 2019, by and between Humanigen, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on November 12, 2019)
- Form of Amendment Number 1, dated October 8, 2019, to the Secured Bridge Note, dated June 28, 2019 (Filed With SEC on October 8, 2019)
- Form of 2019 Convertible Note (Filed With SEC on August 13, 2019)
- Clinical Collaboration Agreement, dated May 30, 2019 between the Registrant and Kite Pharma, Inc (Filed With SEC on August 13, 2019)
- Form of 2019 Bridge Note (Filed With SEC on August 13, 2019)
- Form of Convertible Note (Filed With SEC on November 6, 2018)
- Amended Employment Agreement dated August 22, 2018, between the Company and Jon. G. Jester (Filed With SEC on November 6, 2018)
- Form of Advance Note (Filed With SEC on August 9, 2018)
- Registration Rights Agreement, dated December February 27, 2018 between the Registrant and Black Horse Capital Master Fund, Black Horse Capital, Cheval Holdings, Ltd., and Nomis... (Filed With SEC on May 8, 2018)
- Termination and Release Agreement, dated February 27, 2018, between the Registrant and Black Horse Capital Master Fund, Black Horse Capital, Cheval Holdings, Ltd., and Nomis Bay... (Filed With SEC on May 8, 2018)
- Employment Agreement dated March 9, 2018, between the Company and Jon. G. Jester (Filed With SEC on May 8, 2018)
- Offer Letter, dated August 16, 2017, by and between the Registrant and Greg Jester (Filed With SEC on March 27, 2018)
- Securities Purchase and Loan Satisfaction Agreement dated as of December 21, 2017, by and among the Registrant, Black Horse Capital Master Fund Ltd., Black Horse Capital LP,... (Filed With SEC on March 27, 2018)
- Forbearance and Loan Modification Agreement dated as of December 21, 2017, by and among the Registrant, Black Horse Capital Master Fund Ltd., Black Horse Capital LP, Cheval... (Filed With SEC on March 27, 2018)
- Registration Rights Agreement, dated as of August 23, 2017, by and between the Company and Aperture Healthcare Ventures Ltd (Filed With SEC on August 25, 2017)
- Common Stock Purchase Agreement, dated as of August 23, 2017, by and between the Company and Aperture Healthcare Ventures Ltd (Filed With SEC on August 25, 2017)
- KaloBios Pharmaceuticals, Inc. 1000 Marina Blvd., Suite 250 Brisbane, CA 94005 (Filed With SEC on July 12, 2017)
- KaloBios Pharmaceuticals, Inc. 1000 Marina Blvd., Suite 250 Brisbane, CA 94005 (Filed With SEC on March 23, 2017)
- TERM LOAN NOTE (Filed With SEC on March 23, 2017)
- TERM LOAN NOTE (Filed With SEC on March 23, 2017)
- TERM LOAN NOTE (Filed With SEC on March 23, 2017)
- TERM LOAN NOTE (Filed With SEC on March 23, 2017)
- MASTER CONSULTING AGREEMENT (Filed With SEC on March 9, 2017)
- CREDIT AND SECURITY AGREEMENT dated as of December 21, 2016 by and among KALOBIOS PHARMACEUTICALS, INC. as Borrower, and BLACK HORSE CAPITAL MASTER FUND LTD., as Administrative... (Filed With SEC on December 23, 2016)
- INTELLECTUAL PROPERTY SECURITY AGREEMENT (Filed With SEC on December 23, 2016)
- TERM LOAN NOTE (Filed With SEC on December 23, 2016)
- TERM LOAN NOTE (Filed With SEC on December 23, 2016)
- TERM LOAN NOTE (Filed With SEC on December 23, 2016)
- TERM LOAN NOTE (Filed With SEC on December 23, 2016)
- [Signature Page to Follow] (Filed With SEC on September 23, 2016)
- COMMON STOCK PURCHASE WARRANT KALOBIOS PHARMACEUTICALS, INC. (Filed With SEC on September 23, 2016)
- AMENDMENT NO. TWO TO LOAN AND SECURITY AGREEMENT (Filed With SEC on September 1, 2016)
- CorporateGovernance agreement (Filed With SEC on July 6, 2016)
- IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE (Filed With SEC on June 22, 2016)
- DEBTOR IN POSSESSION CREDIT AND SECURITYAGREEMENT dated as of April 1, 2016 by and among KALOBIOS PHARMACEUTICALS, INC. as Borrower, and BLACK HORSE CAPITAL MASTER FUND LTD., as... (Filed With SEC on April 7, 2016)
- INTELLECTUAL PROPERTY SECURITY AGREEMENT (Filed With SEC on April 7, 2016)
- debtorin possession TERM LOAN NOTE (Filed With SEC on April 7, 2016)
- debtorin possession TERM LOAN NOTE (Filed With SEC on April 7, 2016)
- debtorin possession TERM LOAN NOTE (Filed With SEC on April 7, 2016)
- debtorin possession TERM LOAN NOTE (Filed With SEC on April 7, 2016)
- SECURITIES PURCHASE AGREEMENT BY AND BETWEEN KALOBIOS PHARMACEUTICALS, INC. AND BLACK HORSE CAPITAL LP, BLACK HORSECAPITAL MASTER FUND LTD., CHEVAL HOLDINGS, LTD., AND NOMIS BAY... (Filed With SEC on April 7, 2016)
- AMendmentNo. 1 to Securities Purchase Agreement (Filed With SEC on December 16, 2015)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on December 9, 2015)
- COMMON STOCK PURCHASE WARRANT KALOBIOSPHARMACEUTICALS, INC. (Filed With SEC on December 9, 2015)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 9, 2015)
- SERVICES AGREEMENT (Filed With SEC on December 9, 2015)
- [KALOBIOS LETTERHEAD] (Filed With SEC on August 10, 2015)
- KaloBios Pharmaceuticals, Inc. 2012 Equity Incentive Plan (As Amended and Restated July 14, 2015) (Filed With SEC on August 10, 2015)
- TERMINATION AGREEMENT (Filed With SEC on May 11, 2015)
- KALOBIOS PHARMACEUTICALS, INC. 2012 EQUITY INCENTIVE PLAN NOTICE OF STOCK UNIT AWARD (Filed With SEC on April 24, 2015)
- TERMINATION AGREEMENT (Filed With SEC on November 6, 2014)
- AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on May 8, 2014)
- AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on May 8, 2014)
- AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on May 8, 2014)
- AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on May 8, 2014)
- EMPLOYMENT AGREEMENT (Filed With SEC on May 8, 2014)
- KALOBIOS PHARMACEUTICALS, INC. 2012 EQUITY INCENTIVE PLAN NOTICE OF STOCK OPTION GRANT (Filed With SEC on March 13, 2014)
- KALOBIOS PHARMACEUTICALS, INC. INCENTIVE BONUS PLAN (Filed With SEC on March 13, 2014)
- EMPLOYMENT AGREEMENT (Filed With SEC on March 13, 2014)
- EMPLOYMENT AGREEMENT (Filed With SEC on March 13, 2014)
- EMPLOYMENT AGREEMENT (Filed With SEC on March 13, 2014)
- EMPLOYMENT AGREEMENT (Filed With SEC on March 13, 2014)
- LEASE BRITANNIA LIFE SCIENCE CENTER BAYSIDE ACQUISITION, LLC,, a Delaware limited liability company as Landlord, and KALOBIOS PHARMACEUTICALS, INC., a Delaware corporation, as... (Filed With SEC on March 13, 2014)
- FIRST AMENDMENT TO LEASE (Filed With SEC on November 12, 2013)
- KaloBios Pharmaceuticals, Inc. 7,500,000 Shares Common Stock ($0.001 par value) Underwriting Agreement (Filed With SEC on September 26, 2013)
- AMENDMENT NO. ONE TO LOAN AND SECURITY AGREEMENT (Filed With SEC on June 24, 2013)
- WARRANT TO PURCHASE STOCK (Filed With SEC on June 24, 2013)
- KaloBios Pharmaceuticals, Inc. [ ] Shares Common Stock ($0.001 par value) Underwriting Agreement (Filed With SEC on January 15, 2013)
- KALOBIOS PHARMACEUTICALS, INC. TERMINATION AGREEMENT AND WAIVER (Filed With SEC on October 12, 2012)
- WARRANT TO PURCHASE STOCK (Filed With SEC on October 5, 2012)
- KALOBIOS PHARMACEUTICALS, INC. 2001 STOCK PLAN ADOPTEDON MAY 31, 2001 (AS AMENDED ONJANUARY 26, 2005, JANUARY 9, 2007, JULY 17, 2007, OCTOBER 9, 2007, SEPTEMBER 16, 2008 AND... (Filed With SEC on October 5, 2012)
- 2012 EMPLOYEE STOCK PURCHASE PLAN (AS ADOPTED TO BE EFFECTIVEON THE IPO DATE) KALOBIOS PHARMACEUTICALS, INC. 2012 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on October 5, 2012)
- CONFIDENTIAL TREATMENT REQUESTED SUPPLY AGREEMENT KB001-A bulk (Filed With SEC on October 5, 2012)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on September 7, 2012)
- WARRANT TO PURCHASE STOCK (Filed With SEC on September 7, 2012)
